DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Australia Market Report for Assisted Reproduction Technology 2017 - MedCore" report to their offering.
The assisted reproduction market consists of the oocyte retrieval needle, micropipette, embryo transfer catheter, reproductive media and embryo time-lapse incubator sub-segments. The market value of assisted reproduction devices is tied to the number of cycles performed. In this report, the cycle procedure numbers include both IVF and ICSI cycles.
In assisted reproductive technology, there is no international, or in many cases, national standard protocols in place. This means that labs vary by technique, equipment, types and units of supplies used etc. Part of the differences between country market values is due to procedure number variations, and part of the difference is due to the variations in common lab processes between countries. Reimbursement is one of the predominant factors affecting the number of IVF cycles performed annually and the number of patients seeking treatment. In Australia, reimbursement is available through both public and private insurance; however, it rarely covers 100% of the costs.
The remaining amount will be covered out-of-pocket by the patient. Many other factors are also limited by governments. The number of cycles attempted before pregnancy varies by country, the number of embryos implanted and the age of the potential parents is also a factor. Also, some companies only reimburse certain types of procedures or reimburse some procedures at better rates. Excluding the cost of capital equipment and doctor's fees, there is still a large profit margin to be had by ART clinics.
Key Topics Covered:
1. Research Methodology
2. Disease Overview
3. Product Assessment
4. Assisted Reproduction Technology Device Market
For more information about this report visit http://www.researchandmarkets.com/research/pp2f3w/australia_market